Clinical trial Recruiting at 1 site Observational Ages 18 and up Men only

Aquablation therapy for benign prostate enlargement in Canada

Official title: Canadian Cohort of Aquablation, a Robotically Executed, Surgeon-guided, High-pressure Water Jet Ablation Therapy for Endoscopic Resection of Prostate Tissue, in Benign Prostatic Hyperplasia (BPH).

Run by Can-Am HIFU Inc. · NCT05169892 · Data updated 2026-11-12

This study looks at how well Aquablation therapy works for men with benign prostate enlargement in Canada over three years.

Quick facts

Study typeObservational
Ages18 Years and up
SexMen only
Enrollment25 (estimated)
SponsorCan-Am HIFU Inc.
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedOctober 9, 2019
Main results expectedDecember 31, 2029
Study endsDecember 31, 2030
Registry record updatedAugust 19, 2026
Trial IDNCT05169892 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are male patients aged 18 and older diagnosed with benign prostatic hyperplasia who are suitable for Aquablation therapy.

Probably not a fit

Patients with health conditions that make them unsuitable for the study or those unable to comply with the study protocol may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study documents the clinical outcomes of Aquablation therapy for patients with benign prostatic hyperplasia (BPH) in a Canadian cohort. Male subjects aged 18 and older who are candidates for Aquablation will be followed for three years as part of standard care. The study aims to gather data on the effectiveness and safety of this treatment approach in managing BPH.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the effectiveness of Aquablation therapy, potentially improving treatment options for patients with BPH.

How similar studies have gone: While this study focuses on a specific cohort, similar approaches using Aquablation therapy have shown promise in other settings, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Primary diagnosis of Benign Prostate Hypertrophy (BPH)
* Male subjects of ≥ 18 years of age
* Candidate for Aquablation therapy as per clinical decision of Investigator
* Willing and able to accurately complete questionnaires
* Willing and able to provide signed and dated informed consent

Exclusion Criteria:

* Characteristics indicating a poor compliance with study protocol requirements.
* Disease or other health condition that is not suitable for this study.
* Unable or unwilling to provide signed informed consent.

Where it's running

  • Dean Elterman
    Toronto, Ontario, Canada
    Recruiting

Study contacts

  • Principal investigator: Dean Elterman, MD — University Health Network, Toronto
  • Study coordinator: Iris Chan
  • Email: iris.chan2@uhn.ca
  • Phone: 4166035800

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Urine, perineal, and stool microbiota in children and adolescents

    We will test whether the bacteria in voided urine, around the genitals, and in stool differ between children with overactive bladder or daytime wetting and healthy children of the same age and gender.

    Recruiting at 2 sites Aalborg University Hospital · Aalborg and 3 other locations · NCT07535619

  • 21-day comprehensive spa care for kidney and urinary conditions

    This program will try a 21-day spa treatment with mineral water baths, drinking cures, exercise and diet for adults 40–70 who have chronic kidney or urinary problems to see if it improves symptoms and kidney health.

    Recruiting Institute of Spa and Balneology, public research institution · Mariánské Lázně, Carlsbad Region · NCT07435844

  • Hospital admissions for blood in the urine

    This international observational project will look at how hospitals manage adults admitted with blood in the urine to see which approaches lead to shorter stays and better outcomes.

    Recruiting British Urology Researchers in Surgical Training · London · NCT07395037

  • Using AI language models to help diagnose and recommend treatments for urologic conditions

    This project will test whether three AI language models (ChatGPT, Gemini, DeepSeek) can accurately recognize urologic diseases and suggest diagnoses and treatments from archived hospital records of adult patients.

    Recruiting First Affiliated Hospital of Fujian Medical University · Fuzhou · NCT07378358

  • Virtual reality to reduce pain and anxiety during outpatient urology procedures

    This trial will try a virtual reality headset (REALICA®) to reduce pain and anxiety for adults having outpatient urology procedures such as circumcision, prostate biopsy, or flexible cystoscopy.

    Recruiting Istituto Oncologico Veneto IRCCS · Padova · NCT07338292

  • Using vorolanib for treating advanced kidney cancer

    This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.

    Recruiting Jinling Hospital, China · Nanjing, Jiangsu · NCT06676527

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.